Lp-PLA2 is also known as platelet-activating factor acetylhydrolase, and it is mainly produced by monocytes and macrophages [10]. Studies have demonstrated that Lp-PLA2 activity acts as a predictor of coronary artery disease and stroke independently [10]. Higher levels of Lp-PLA2 have been linked to a higher cardiovascular risk, regardless of other contributing factors [10,23]. This evidence concerns the gene PLA2G7 and stroke disorder.